Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells. 1977

G N Douglas, and A S Rubin

In cultures of spleen cells from mice immunized with horse erythrocytes (HRBC) 7 days earlier, the simultaneous addition of sheep erythrocytes (SRBC) and the priming antigen on day 0 resulted in the suppression of the anti-SRBC plaque-forming cell (PFC) response by day 5 compared to the response of similar cultures that received only SRBC. The cell-free culture fluid from specifically-stimulated, HRBC-primed cells, but not normal cells, contained a factor that nonspecifically inhibited the anti-SRBC PFC response of cultures of normal spleen cells to which SRBC and diluted supernatant aliquots were added at the beginning of culture. Suppressor activity was not manifest unless active supernatants were added on day 0 of a 5-day culture period. Inhibition of the reference plaque response was not due to cytotoxicity of the active material, decreased immunogenicity of the SRBC, or switchover from IgM to IgG plaque formation. The soluble mediator was released slowly into the culture fluid, with linear kinetics, from specifically activated, primed cells, with maximum suppression obtained with the 120-h supernatant. When active supernatants were fractionated by gel filtration over Sephadex G-150, the inhibitory factor eluted with molecules of about 34,000 mol. wt.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D005260 Female Females
D006462 Hemolytic Plaque Technique A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed) Jerne's Plaque Technique,Hemolytic Plaque Technic,Jerne's Plaque Technic,Hemolytic Plaque Technics,Hemolytic Plaque Techniques,Jerne Plaque Technic,Jerne Plaque Technique,Jernes Plaque Technic,Jernes Plaque Technique,Plaque Technic, Hemolytic,Plaque Technic, Jerne's,Plaque Technics, Hemolytic,Plaque Technique, Hemolytic,Plaque Technique, Jerne's,Plaque Techniques, Hemolytic,Technic, Hemolytic Plaque,Technic, Jerne's Plaque,Technics, Hemolytic Plaque,Technique, Hemolytic Plaque,Technique, Jerne's Plaque,Techniques, Hemolytic Plaque
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

G N Douglas, and A S Rubin
August 1968, Nature,
Copied contents to your clipboard!